Kerr Drug Chain of the Year Obesity screening and diet counseling Volunteer pharmacists ease suffering in Haiti FDA safety page : Kapidex becomes Dexilant
Obesity-Related Mortality Rose After COVID-19 Pandemic | ADA 2025
In a retrospective study of obesity-related mortality, researchers explored US death trends before, during, and after the COVID-19 pandemic.
The Independent Pharmacist Championing Innovative, Patient-Centric Care
Amid the continuously evolving role of pharmacists in today’s health care landscape, independent owners like Amina Abubakar, PharmD, AAHIVP, are advancing the profession through innovation.
Telemedicine With GLP-1 Behavior Program Shows Significant Declines in Weight, Blood Pressure | ADA 2025
In a real-world, 6-month analysis, glucagon-like peptide-1 programs with obesity telemedicine behavioral programs resulted in benefits to weight loss and blood pressure.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Younger Adults Disproportionately Not Treated for Cardiometabolic Risk Factors | ADA 2025
When compared with adults 45 years and older, those 18 to 44 years are less likely to receive treatment or achieve target goals for cardiometabolic risk factors.
CGM Usage Improves Glycemic, Psychosocial Outcomes for Type 1 Diabetes | ADA 2025
Investigators assessed continuous glucose monitoring with behavioral intervention for patients with type 1 diabetes.